Back | Next |
home / stock / amrn / amrn message board
Subject | By | Source | When |
---|---|---|---|
Stockboy, Have you considered the possibility, that no | Number sleven | investorshub | 04/21/2024 3:01:30 AM |
Fact: It doesn't matter if one carbon, one | Mr Stockboy | investorshub | 04/21/2024 2:12:09 AM |
Amarin should create an E-EPA patent distinguished from | Mr Stockboy | investorshub | 04/21/2024 2:08:46 AM |
Any schooled, educated, astute lawyer would grasp EPA | Mr Stockboy | investorshub | 04/21/2024 2:02:38 AM |
https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2024/04/19/15/28/lipoprot | DMC8 | investorshub | 04/20/2024 8:43:55 AM |
Chief Judge Moore already knew it, she prompted | DMC8 | investorshub | 04/20/2024 7:53:23 AM |
My bad a typo, should be May 01, 2024.* | DMC8 | investorshub | 04/20/2024 7:48:34 AM |
Hopefully a typo, May 2023.. | scxj | investorshub | 04/20/2024 2:59:17 AM |
Amarin needs to start defending E-EPA, and the | Mr Stockboy | investorshub | 04/20/2024 1:28:09 AM |
You expecting me to cry? | Mr Stockboy | investorshub | 04/20/2024 1:26:56 AM |
A gentle reminder KMs stock option will expire | DMC8 | investorshub | 04/20/2024 1:20:52 AM |
ziploc1 IMO Should be a requirement for ALL skinny | hayward | investorshub | 04/19/2024 11:53:01 PM |
DMC8....In Hikmas press release Hikma refered to multiple | ziploc_1 | investorshub | 04/19/2024 9:21:21 PM |
Yes, we knew this was coming...... so no | ramfan60 | investorshub | 04/19/2024 9:14:44 PM |
Thanks, Michael. | RobinF | investorshub | 04/19/2024 9:05:00 PM |
RobinF Looks like they all received 180,000 at .87 | hayward | investorshub | 04/19/2024 9:03:53 PM |
Buy back as much as possible before announcing | roadkilll | investorshub | 04/19/2024 9:01:42 PM |
Any idea whats going on with the Form 4s? | RobinF | investorshub | 04/19/2024 8:53:45 PM |
Form 4 overload | ramfan60 | investorshub | 04/19/2024 8:50:32 PM |
That would be really relly disappointing to | seve333 | investorshub | 04/19/2024 6:31:27 PM |
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
-- VASCEPA Approved by the National Medical Products Administration (NMPA) To Reduce the Risk of Cardiovascular Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT -- ...
-- Board Appoints Aaron Berg as President & CEO -- -- Patrick Holt to Step Down as President & CEO to Pursue Other Opportunities -- DUBLIN and BRIDGEWATER, N.J., June 04, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that the Company’...
-- Greek Ministry of Health approved VAZKEPA ® (icosapent ethyl) for national reimbursement to reduce cardiovascular risk in statin-treated adult patients with elevated triglycerides (≥ 150 mg/ml [≥ 1.7 mmol/l) and other high-risk characteristics as studied in REDUCE-IT ...